Aleksi Tornio - UTU Research Portal

Aleksi Tornio

- Associate Professor,
Institute of Biomedicine (Faculty of Medicine)

aleksi.tornio@utu.fi

+358 29 450 4608

+358 50 476 5715

Kiinamyllynkatu 10

Turku

ORCID identifier: https://orcid.org/0000-0001-5713-5692

Areas of expertise

Clinical Pharmacology; Pharmacokinetics; Drug-drug interactions; Pharmacogenetics

Publications

6 of 9

CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or Prasugrel (2019)
- Clinical Pharmacology and Therapeutics
Holmberg MT, Tornio A, Paile-Hyvarinen M, Tarkiainen EK, Neuvonen M, Neuvonen PJ, Backman JT, Niemi M
(A1 Refereed original research article in a scientific journal)
Enantiospecific Pharmacogenomics of Fluvastatin (2019)
- Clinical Pharmacology and Therapeutics
Hirvensalo P, Tornio A, Neuvonen M, Kiander W, Kidron H, Paile-Hyvarinen M, Tapaninen T, Backman JT, Niemi M
(A1 Refereed original research article in a scientific journal)
Farmakogenetiikan merkitys lääkehoidolle (2019) Lääketieteellinen farmakologia ja toksikologia Mikko Niemi, Miia Turpeinen, Aleksi Tornio
(D2 Article in a professional compilation book)
Farmakokinetiikkaan vaikuttavat perintötekijät (2019) Lääketieteellinen farmakologia ja toksikologia Mikko Niemi, Miia Turpeinen, Aleksi Tornio
(D2 Article in a professional compilation book)
Itraconazole Increases Ibrutinib Exposure 10-Fold and Reduces Interindividual Variation-A Potentially Beneficial Drug-Drug Interaction (2019)
- Clinical and Translational Science
Tapaninen T, Olkkola AM, Tornio A, Neuvonen M, Elonen E, Neuvonen PJ, Niemi M, Backman JT
(A1 Refereed original research article in a scientific journal)
(2019) Lääketieteellinen farmakologia ja toksikologia Mikko Niemi, Miia Turpeinen, Aleksi Tornio
(D2 Article in a professional compilation book)
Response to "Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?" (2019) Itkonen MK, Tornio A, Lapatto-Reiniluoto O, Neuvonen M, Neuvonen PJ, Niemi M, Backman JT
(Other publication)
Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans (2018)
- Clinical Pharmacology and Therapeutics
Itkonen MK, Tornio A, Filppula AM, Neuvonen M, Neuvonen PJ, Niemi M, Backman JT
(A1 Refereed original research article in a scientific journal)
Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions (2018)
- Drug Metabolism and DispositionClinical Pharmacology and Therapeutics
Kahma H, Filppula AM, Neuvonen M, Tarkiainen EK, Tornio A, Holmberg MT, Itkonen MK, Finel M, Neuvonen PJ, Niemi M, Backman JT
(A1 Refereed original research article in a scientific journal)
Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics (2018)
Hirvensalo P, Tornio A, Neuvonen M, Tapaninen T, Paile-Hyvarinen M, Karja V, Mannisto VT, Pihlajamaki J, Backman JT, Niemi M
(A1 Refereed original research article in a scientific journal)